The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study.
Institute of Biomedical Engineering, College of Medicine and College of Engineering, National Taiwan University, Taipei, Taiwan; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Department of Dermatology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
Hsien-Yi
HY
Chiu
Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: tftsai@yahoo.com.
Tsen-Fang
TF
Tsai
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D004279:DNA, Viral / Q000032:analysis; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005138:Eyebrows / Q000821:virology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009333:Neck / Q000821:virology; D027383:Papillomaviridae / Q000235:genetics / Q000302:isolation & purification*; D010865:Pilot Projects; D011446:Prospective Studies; D011565:Psoriasis / Q000188:drug therapy* / Q000821:virology; D012720:Severity of Illness Index; D012867:Skin / Q000821:virology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D004279:DNA, Viral; D003879:Dermatologic Agents; C555450:secukinumab